GHRS (GH Research PLC) חוב לטווח קצר להון

The market trend for GH Research PLC (GHRS) shares reflects the dynamics of a company developing inhalation antidepressants protected by global patents, where the indicator stands at 0.00. The development of innovative psychedelics is currently in the testing phase, carving a high-risk path toward market entry. Business success depends on the results of medical trials, remaining virtually independent of market cycles and macroeconomics.

This indicator measures the proportion of short-term borrowings within the equity structure, determining the company's reliance on the operational refinancing of liabilities. For GH Research PLC (GHRS), which invests in energy-efficient laboratories and ESG standards, this balance is critical for sustaining bioethical research without liquidity risk, a fact clearly reflected in the changing ratio of current liabilities to equity.